Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Strategic Perspectives 2001 Phobias: Patient Barriers to Antidepressant Revenues

Published by: Datamonitor

Published: Aug. 31, 2001 - 75 Pages


Table of Contents


DATAMONITOR HEALTHCARE

CONTACT DETAILS

Global Director of CNS

EXECUTIVE SUMMARY

Scope

Datamonitor insight into the phobias market

Key metrics

TABLE OF CONTENTS

EPIDEMIOLOGY

Phobias overview

Specific phobia

Agoraphobia

Comorbidities

Patient potential

Prevalence

Epidemiological conclusion

CLINICAL PRACTICE

Introduction

Diagnosis

Guidelines in existence

Physician diagnosis rate

Treatment

Breakdown of phobias in anxiety disorders

First line phobia treatment

Overall phobia treatment

Influence on phobia marketing

Physician skepticism of pharmacological therapy

Current drug choice is based upon experience

The need to treat comorbid conditions

CURRENT PHOBIAS MARKET

Clinical research

Antidepressant treatment of phobias

Paxil

Prozac

Luvox

Other antidepressants

Antidepressant conclusion

Other drugs used to treat phobias

Benzodiazepines

Conclusion

The global phobias market 2001

Specific phobia

Agoraphobia

THE FUTURE DECODED

Unmet needs in treating phobia

The phobia R&D pipeline

An ideal drug candidate

The phobias market 2001-2008

Phobia market forecasts to 2008

Specific phobia

Agoraphobia

APPENDIX

Datamonitor's Central Nervous System Business Unit

Table of tables

Epidemiological bibliography

Clinical trials

Websites

R&D research methodology

Introduction

Hypothesis formulation

Hypothesis testing

Data verification and quality control

Physician research questionnaire

Diagnosis

Treatment

Unmet needs

Pricing data

Introduction

Source prices

Ex-manufacturer, wholesaler and retail prices

Data validation and margin calculation

Quality control

Patent expiries





































Abstract

Datamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder.

Anxiety Disorders covered:

  • Eating Disorders (Anorexia Nervosa and Bulimia Nervosa)
  • Generalized Anxiety Disorder
  • Obsessive Compulsive Disorder
  • Panic Disorder
  • Phobias (Specific Phobia and Agoraphobia)
  • Post Traumatic Stress Disorder
  • Premenstrual Dysphoric Disorder
  • Social Anxiety Disorder

    Get Full Details About This Report >>
  • US: 800.298.5699
    Int'l: +1.240.747.3093
    Buy this Report

    Price and Delivery Options

    See related reports or call the number above for help from a research specialist.


     

    About MarketResearch.com
    MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

     

    © MarketResearch.com 2008